Published in Br J Cancer on November 01, 1983
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol (1987) 5.00
Epidemiology and causation: a realist view. J Epidemiol Community Health (1994) 1.99
Risk factors in the development of cervical intraepithelial neoplasia in women with vulval warts. Genitourin Med (1988) 1.21
Sex and cervical cancer. Genitourin Med (1988) 0.91
Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol (1997) 0.90
Comparison of women with cervical human papillomavirus infection and genital warts. I. Some behavioural factors and clinical findings. Genitourin Med (1995) 0.90
Pathogenesis of genital HPV infection. Genitourin Med (1993) 0.87
Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol (1994) 0.81
Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer (2002) 0.80
A case-control study of cervix cancer in Singapore. Br J Cancer (1989) 0.79
Anogenital warts: epidemiology, treatment and association with cervical atypia. Ulster Med J (1987) 0.75
Pneumococcal vaccine and HIV infection. Genitourin Med (1995) 0.75
Increased incidence of cervical cytological abnormalities in women with genital warts. Genitourin Med (1992) 0.75
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Estimability and estimation in case-referent studies. Am J Epidemiol (1976) 22.43
Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet (1982) 4.31
Problems of cell nomenclature in cervical cytology smears. Recommendations of a working party of the British Society for Clinical Cytology. J Clin Pathol (1978) 3.32
Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer (1982) 2.76
Noncondylomatous cervical wart virus infection. Obstet Gynecol (1980) 1.79
Human cervical cancer as a venereal disease. Cancer Res (1976) 1.53
Cytology of gynecologic condyloma acuminatum. Acta Cytol (1977) 1.51
Carbon dioxide laser treatment for condylomata acuminata venereal infections. Obstet Gynecol (1980) 1.22
Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix. Acta Cytol (1981) 1.12
Possible etiologies of cancer of the cervix other than herpesvirus. Cancer Res (1973) 1.10
Condylomata acuminata and squamous cell carcinoma. Urology (1977) 1.10
Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms. Cancer Res (1981) 1.07
DNA content of condyloma acuminatum. Cancer (1982) 0.93
[Histopathologic and cytophotometric study of dysplastic and precancerous condyloma acuminata(author's transl)]. Arch Gynakol (1974) 0.87
Simultaneous condyloma acuminatum and dysplasia of the uterine cervix. Acta Cytol (1981) 0.86
Association of human papillomavirus with neoplastic processes in the genital tract of four women with impaired immunity. Gynecol Oncol (1981) 0.86
Human cancers and human viruses. Br Med J (Clin Res Ed) (1982) 0.83
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09
Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82
A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ (2000) 11.35
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53
Use of medicines in general practice. Br Med J (1977) 8.38
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
Why do we need some large, simple randomized trials? Stat Med (1985) 7.67
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18
Investigation into use of drugs preceding death from asthma. Br Med J (1968) 6.76
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol (1999) 6.42
Women with positive cervical smears but without surgical intervention. A follow-up study. Lancet (1978) 6.40
The European mesothelioma epidemic. Br J Cancer (1999) 6.28
Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ (1998) 6.13
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.86
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J (1965) 5.67
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest (1971) 5.53
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.50
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (1988) 5.45
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet (2011) 5.08
Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet (1977) 5.00
The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis (1983) 4.90
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Mortality from lung cancer and other causes among workers in an asbestos textile factory. Br J Ind Med (1968) 4.81
The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954. Int J Epidemiol (2004) 4.66
Mortality among doctors in different occupations. Br Med J (1977) 4.60
Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ (1998) 4.51
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50
Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Tobacco--the growing epidemic. Nat Med (1999) 4.31
100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol (2001) 4.25
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA (1997) 4.09
Mortality of British doctors in relation to smoking: observations on coronary thrombosis. Natl Cancer Inst Monogr (1966) 3.92
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69
Immunosurveillance and cancer: epidemiological evidence. Br Med J (1970) 3.68
Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res (1976) 3.58
Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ (1997) 3.51
Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut (1968) 3.46
Why do we need systematic overviews of randomized trials? Stat Med (1987) 3.33
What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17
How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. BMJ (1998) 3.10
A mathematical model for the age distribution of cancer in man. Int J Cancer (1969) 3.08